Anqi Gao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Anqi Gao has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Caihong Wang
Department of Rheumatology, The Second Hospital of Shanxi Medical University, Taiyuan, China
2 shared publications Chong Gao
Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School , Boston, MA
2 shared publicationsRuqing Jin
Department of Rheumatology, The Second Hospital of Shanxi Medical University , Taiyuan, Shanxi
2 shared publicationsFurong Wu
Shanghai Clinical Research Center for Tuberculosis, Shanghai Pulmonary Hospital, Tongji University School of Medicine, 507 Zhengmin Road, Shanghai, 200433, China
1 shared publicationJing Luo
Department of Rheumatology, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China; Shanxi Key Laboratory for Immunomicroecology, Shanxi, China
1 shared publicationLiangjing Chen
School of Public Health, Shanxi Medical University, Taiyuan, Shanxi, 030001, China
1 shared publication
Latest Publications
- 23 February 2026
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 65 (3)
Distinct immunological features characterize early-onset primary Sjögren’s disease
Objectives: Early-onset primary Sjögren’s disease (pSjD) represents a specific clinical phenotype with poorer prognosis. We aim to compare early- and late-onset pSjD immunophenotypes to identify key distinct immunological features. Methods: We retrospectively studied 204 newly diagnosed, untreated pSjD patients categorized by age at diagnosis (≤35 years). Clinical features, peripheral lymphocyte profiles, CD4+ T cell subsets and cytokine levels were compared. Key immune variables were screened via random forest and LASSO regression. LASSO-selected variables were analysed using forward stepwise logistic regression to determine independent immune factors associated with early-onset pSjD. Results: Among 204 enrolled patients, 43 (21.08%) were classified as early-onset pSjD and 161 (78.92%) as late-onset pSjD. Compared with the late-onset group, early-onset patients showed significantly lower CD4+ T cell counts [442.62 (236.92–558.89) vs 563.11 (386.98–762.60), P = 0.005] and NK cell counts [71.36 (51.69–134.58) vs 138.05 (91.65–241.90), P < 0.001]. In terms of CD4+ T cell subsets, the early-onset group exhibited higher Th17/Treg cell ratios [0.42 (0.33–0.59) vs 0.30 (0.21–0.46), P = 0.006] and lower Treg cell counts [22.07 (12.89–34.96) vs 28.00 (20.35–38.93), P = 0.032]. Three independent factors for early-onset disease were identified: NK cell counts (OR = 0.993, P = 0.010), CD4+ T cell percentage (OR = 0.947, P = 0.019) and Th17/Treg cell ratios (OR = 5.215, P = 0.029). Conclusion: This study characterizes the distinct peripheral immunological landscapes of early- and late-onset pSjD and identifies an immunological triad that may represent a unique ‘immune endotype’ for early-onset disease, offering insights into targeted monitoring and therapies.
- 23 February 2026
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 65 (3)
Distinct immunological features characterize early-onset primary Sjögren’s disease
Objectives: Early-onset primary Sjögren’s disease (pSjD) represents a specific clinical phenotype with poorer prognosis. We aim to compare early- and late-onset pSjD immunophenotypes to identify key distinct immunological features. Methods: We retrospectively studied 204 newly diagnosed, untreated pSjD patients categorized by age at diagnosis (≤35 years). Clinical features, peripheral lymphocyte profiles, CD4+ T cell subsets and cytokine levels were compared. Key immune variables were screened via random forest and LASSO regression. LASSO-selected variables were analysed using forward stepwise logistic regression to determine independent immune factors associated with early-onset pSjD. Results: Among 204 enrolled patients, 43 (21.08%) were classified as early-onset pSjD and 161 (78.92%) as late-onset pSjD. Compared with the late-onset group, early-onset patients showed significantly lower CD4+ T cell counts [442.62 (236.92–558.89) vs 563.11 (386.98–762.60), P = 0.005] and NK cell counts [71.36 (51.69–134.58) vs 138.05 (91.65–241.90), P < 0.001]. In terms of CD4+ T cell subsets, the early-onset group exhibited higher Th17/Treg cell ratios [0.42 (0.33–0.59) vs 0.30 (0.21–0.46), P = 0.006] and lower Treg cell counts [22.07 (12.89–34.96) vs 28.00 (20.35–38.93), P = 0.032]. Three independent factors for early-onset disease were identified: NK cell counts (OR = 0.993, P = 0.010), CD4+ T cell percentage (OR = 0.947, P = 0.019) and Th17/Treg cell ratios (OR = 5.215, P = 0.029). Conclusion: This study characterizes the distinct peripheral immunological landscapes of early- and late-onset pSjD and identifies an immunological triad that may represent a unique ‘immune endotype’ for early-onset disease, offering insights into targeted monitoring and therapies.
- 7 November 2022
- Published by Elsevier in Journal of Autoimmunity
- Vol. 133, 102950
Tissue-resident memory T cells: The key frontier in local synovitis memory of rheumatoid arthritis
- 7 November 2022
- Published by Elsevier in Journal of Autoimmunity
- Vol. 133, 102950
Tissue-resident memory T cells: The key frontier in local synovitis memory of rheumatoid arthritis
- 1 June 2021
- Published by Elsevier in European Journal of Pharmacology
- Vol. 900, 174046
Up-regulation of nPKC contributes to proliferation of mice pulmonary artery smooth muscle cells in hypoxia-induced pulmonary hypertension
- 1 June 2021
- Published by Elsevier in European Journal of Pharmacology
- Vol. 900, 174046
Up-regulation of nPKC contributes to proliferation of mice pulmonary artery smooth muscle cells in hypoxia-induced pulmonary hypertension